research Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
This review examines the patent literature on AKR1C3 inhibitors and suggests that although numerous potent inhibitors exist, further preclinical optimization is necessary before assessing their therapeutic potential in human diseases.